Your browser doesn't support javascript.
loading
Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase.
Bennett, Ryan P; Yoluç, Yasemin; Salter, Jason D; Ripp, Alexander; Jessen, Henning J; Kaiser, Stefanie M; Smith, Harold C.
Afiliação
  • Bennett RP; OyaGen, Inc., Rochester, NY, USA. Electronic address: rbennett@oyageninc.com.
  • Yoluç Y; Department of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany. Electronic address: yasemin.yoluc@hotmail.de.
  • Salter JD; OyaGen, Inc., Rochester, NY, USA. Electronic address: jsalter@oyageninc.com.
  • Ripp A; Institute of Organic Chemistry Albert-Ludwigs-University, Freiburg, Germany. Electronic address: alexander.ripp@livmats.uni-freiburg.de.
  • Jessen HJ; Institute of Organic Chemistry Albert-Ludwigs-University, Freiburg, Germany. Electronic address: henning.jessen@oc.uni-freiburg.de.
  • Kaiser SM; Department of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany. Electronic address: stefanie.kaiser@pharmchem.uni-frankfurt.de.
  • Smith HC; OyaGen, Inc., Rochester, NY, USA; Department of Biochemistry and Biophysics, Center for RNA Biology, Center for AIDS Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. Electronic address: hsmith@oyageninc.com.
Antiviral Res ; 218: 105716, 2023 10.
Article em En | MEDLINE | ID: mdl-37690700

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Antiviral Res Ano de publicação: 2023 Tipo de documento: Article